STXS - Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.
As of May 15, 2026: spot at $1.88, ATM IV 358.8%, net GEX $1.4K.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Market Cap
- $180.3M
- Beta
- 1.33
- 52-Week Range
- 1.74-3.59
- CEO
- David Leo Fischel
- Employees
- 139
- IPO Date
- Aug 12, 2004
- Exchange
- AMEX
What STXS Looks Like to Options Traders Today
IV rank of 100.0% signals elevated pricing relative to the 1-year history, conditions that typically favor premium-selling structures (credit spreads, iron condors, covered calls); positive net gamma exposure ($1.4K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes.
What This Page Covers
The STXS overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked STXS overview questions
- What is STXS?
- STXS is the ticker symbol for Stereotaxis, Inc., a listed security. Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Listed on AMEX. STXS is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the STXS options snapshot look like today?
- As of May 15, 2026, the STXS options snapshot shows spot at $1.88, ATM IV 358.8%, IV rank 100.0%, net GEX $1.4K, expected move 102.87%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are STXS's key statistics?
- Stereotaxis, Inc. (STXS) carries a market capitalization of $180.3M, beta of 1.33 relative to the broader market, 52-week range of 1.74-3.59. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does STXS belong to?
- Stereotaxis, Inc. operates in the Healthcare sector, in the Medical - Instruments & Supplies industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare STXS's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the STXS data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).